Shravan Morla

492 total citations
14 papers, 390 citations indexed

About

Shravan Morla is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Shravan Morla has authored 14 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Organic Chemistry. Recurrent topics in Shravan Morla's work include Glycosylation and Glycoproteins Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Shravan Morla is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Shravan Morla collaborates with scholars based in United States, India and Australia. Shravan Morla's co-authors include Umesh R. Desai, Dharmarajan Sriram, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Variam Ullas Jeankumar, Janupally Renuka, Bhaumik B. Patel, Chetna Sharon, Donald F. Brophy and Srihari Konduri and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and International Journal of Molecular Sciences.

In The Last Decade

Shravan Morla

14 papers receiving 388 citations

Peers

Shravan Morla

Yukiko Hiraiwa Japan

Junichi Taira Japan

Pablo Ríos‐Marco Spain

Frédéric Couture Canada

Chetna Sharon United States

Matt Nodwell Canada

Min Guan China

Chunling Jiang China

Xiuhua Wu China

Yukiko Hiraiwa Japan

Shravan Morla

162 ×0.8

73 ×0.6

53 ×0.6

36 ×0.7

82 ×1.6

Citations per year, relative to Shravan Morla Shravan Morla (= 1×) peers Yukiko Hiraiwa

Countries citing papers authored by Shravan Morla

Since Specialization

Citations

This map shows the geographic impact of Shravan Morla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shravan Morla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shravan Morla more than expected).

Fields of papers citing papers by Shravan Morla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shravan Morla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shravan Morla. The network helps show where Shravan Morla may publish in the future.

Co-authorship network of co-authors of Shravan Morla

This figure shows the co-authorship network connecting the top 25 collaborators of Shravan Morla. A scholar is included among the top collaborators of Shravan Morla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shravan Morla. Shravan Morla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Morla, Shravan, Alberto Vera, Daniel K. Afosah, et al.. (2023). Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity. Journal of Medicinal Chemistry. 66(2). 1321–1338. 7 indexed citations

Parker, Mackenzie J., Hyelee Lee, Shihua Yao, et al.. (2023). Identification of 2-Sulfonyl/Sulfonamide Pyrimidines as Covalent Inhibitors of WRN Using a Multiplexed High-Throughput Screening Assay. Biochemistry. 62(14). 2147–2160. 16 indexed citations

Morla, Shravan, Hiroshi Deguchi, Jevgenia Zilberman‐Rudenko, et al.. (2022). Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation. Journal of Biological Chemistry. 298(2). 101567–101567. 8 indexed citations

Othman, Maha, Geoffrey D. Barnes, Jean M. Connors, et al.. (2021). Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience. Research and Practice in Thrombosis and Haemostasis. 5(2). 253–260. 6 indexed citations

Morla, Shravan, Hiroshi Deguchi, & John H. Griffin. (2020). Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin‐dependent anticoagulant activity. Journal of Thrombosis and Haemostasis. 19(2). 470–477. 1 indexed citations

Deguchi, Hiroshi, Shravan Morla, & John H. Griffin. (2020). Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin. Journal of Thrombosis and Haemostasis. 19(1). 7–19. 9 indexed citations

Morla, Shravan & Umesh R. Desai. (2020). Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8. Biomolecules. 10(8). 1166–1166. 6 indexed citations

Al‐Horani, Rami A., Daniel K. Afosah, Shravan Morla, et al.. (2019). A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding. Journal of Thrombosis and Haemostasis. 17(12). 2110–2122. 24 indexed citations

Morla, Shravan. (2019). Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation. International Journal of Molecular Sciences. 20(8). 1963–1963. 171 indexed citations

10.

Morla, Shravan, Nehru Viji Sankaranarayanan, Daniel K. Afosah, et al.. (2019). On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients. Journal of Medicinal Chemistry. 62(11). 5501–5511. 15 indexed citations

11.

Sharon, Chetna, Shravan Morla, Donald F. Brophy, et al.. (2018). A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. Molecular Cancer Therapeutics. 18(1). 51–61. 31 indexed citations

12.

Morla, Shravan, Alhumaidi B. Alabbas, Ravi Kalathur, et al.. (2018). Polymeric fluorescent heparin as one-step FRET substrate of human heparanase. Carbohydrate Polymers. 205. 385–391. 18 indexed citations

13.

Renuka, Janupally, Srihari Konduri, Variam Ullas Jeankumar, et al.. (2014). Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 22(17). 4924–4934. 46 indexed citations

14.

Jeankumar, Variam Ullas, Janupally Renuka, Vijay Soni, et al.. (2013). Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: Scaffold hopping from known antibacterial leads. International Journal of Antimicrobial Agents. 43(3). 269–278. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact